540 related articles for article (PubMed ID: 18581185)
1. Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy.
Yau T; Lo CY; Epstein RJ; Lam AK; Wan KY; Lang BH
Ann Surg Oncol; 2008 Sep; 15(9):2500-5. PubMed ID: 18581185
[TBL] [Abstract][Full Text] [Related]
2. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.
Haigh PI; Ituarte PH; Wu HS; Treseler PA; Posner MD; Quivey JM; Duh QY; Clark OH
Cancer; 2001 Jun; 91(12):2335-42. PubMed ID: 11413523
[TBL] [Abstract][Full Text] [Related]
3. Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: analysis of the surveillance, epidemiology, and end results 1983-2002.
Chen J; Tward JD; Shrieve DC; Hitchcock YJ
Am J Clin Oncol; 2008 Oct; 31(5):460-4. PubMed ID: 18838882
[TBL] [Abstract][Full Text] [Related]
4. Effect of primary treatment on survival in anaplastic thyroid carcinoma.
Besic N; Auersperg M; Us-Krasovec M; Golouh R; Frkovic-Grazio S; Vodnik A
Eur J Surg Oncol; 2001 Apr; 27(3):260-4. PubMed ID: 11373102
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors.
Kebebew E; Greenspan FS; Clark OH; Woeber KA; McMillan A
Cancer; 2005 Apr; 103(7):1330-5. PubMed ID: 15739211
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups.
Heron DE; Karimpour S; Grigsby PW
Am J Clin Oncol; 2002 Oct; 25(5):442-6. PubMed ID: 12393980
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of anaplastic thyroid carcinoma. Our experience.
Palestini N; Brignardello E; Freddi M; Piovesan A; Pipitone Federico NS; Sisto G; Robecchi A
G Chir; 2010; 31(6-7):282-5. PubMed ID: 20646371
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic thyroid carcinoma: a 50-year experience at a single institution.
McIver B; Hay ID; Giuffrida DF; Dvorak CE; Grant CS; Thompson GB; van Heerden JA; Goellner JR
Surgery; 2001 Dec; 130(6):1028-34. PubMed ID: 11742333
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic thyroid carcinoma: dismal outcome despite current treatment approach.
Veness MJ; Porter GS; Morgan GJ
ANZ J Surg; 2004 Jul; 74(7):559-62. PubMed ID: 15230790
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma.
Orita Y; Sugitani I; Matsuura M; Ushijima M; Tsukahara K; Fujimoto Y; Kawabata K
Surgery; 2010 Mar; 147(3):424-31. PubMed ID: 20176243
[TBL] [Abstract][Full Text] [Related]
11. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
Haq M; Harmer C
Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy.
Junor EJ; Paul J; Reed NS
Eur J Surg Oncol; 1992 Apr; 18(2):83-8. PubMed ID: 1582515
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of anaplastic thyroid carcinoma.
Kihara M; Miyauchi A; Yamauchi A; Yokomise H
Surg Today; 2004; 34(5):394-8. PubMed ID: 15108075
[TBL] [Abstract][Full Text] [Related]
14. [Treatment and prognosis of anaplastic thyroid carcinoma].
Sun CZ; Chen FJ; Zeng ZY; Chen YF; Li QL; Guan Z; Tian SZ
Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(21):1493-7. PubMed ID: 17349179
[TBL] [Abstract][Full Text] [Related]
15. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
Liu WS; Qi YF; Tang PZ
Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
[TBL] [Abstract][Full Text] [Related]
16. Anaplastic thyroid carcinoma. Practical aspects of multimodal therapy and data emerging from a 40-year experience at a single Italian institution.
Baroli A; Pedrazzini L; Lomuscio G; Marzoli L
Minerva Endocrinol; 2010 Mar; 35(1):9-16. PubMed ID: 20386523
[TBL] [Abstract][Full Text] [Related]
17. Hyperfractionated Accelerated Radiotherapy (HART) for anaplastic thyroid carcinoma: toxicity and survival analysis.
Dandekar P; Harmer C; Barbachano Y; Rhys-Evans P; Harrington K; Nutting C; Newbold K
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):518-21. PubMed ID: 19395202
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid.
Sugitani I; Kasai N; Fujimoto Y; Yanagisawa A
World J Surg; 2001 May; 25(5):617-22. PubMed ID: 11369989
[TBL] [Abstract][Full Text] [Related]
19. Long-term results in elderly patients with differentiated thyroid carcinoma.
Vini L; Hyer SL; Marshall J; A'Hern R; Harmer C
Cancer; 2003 Jun; 97(11):2736-42. PubMed ID: 12767085
[TBL] [Abstract][Full Text] [Related]
20. Anaplastic thyroid cancer: prevalence, diagnosis and treatment.
Chiacchio S; Lorenzoni A; Boni G; Rubello D; Elisei R; Mariani G
Minerva Endocrinol; 2008 Dec; 33(4):341-57. PubMed ID: 18923370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
